Included below are news items from the last six months.
The FDA has approved the first blood-based genetic test to guide the treatment of a common type of lung cancer called non-small cell lung cancer (NSCLC). The test is less invasive, requiring only a blood draw instead of a traditional tissue biopsy, and detects mutations that could indicate that the tumor is more likely to respond to the drug erlotinib. Photo source: NHGRI, Ernesto del Aguila III
Bacteria with Antibiotic Resistance MCR-1 Gene Found for the First Time in U.S. Patient, Raises Concern
Worry about antibiotic resistance recently intensified when it was discovered for the first time that a strain of the bacteria infecting a patient in the U.S. carries the gene called mcr-1. The gene makes the bacteria resistant to colistin, a polymyxin, which is a class of antibiotics considered to be a "last resort" to treat patients with multidrug-resistant infections. Photo source: NHGRI, Darryl Leja
To make it easier for people to get recommended cholesterol testing, fasting should not be required, according to new European guidelines. So far, no U.S. guidelines for adults have been published recommending such a change.
The amount of blood drawn for laboratory tests has been shown to have a direct relationship to patients' ill health. While collecting the very minimal amount of blood required for testing reduces risks, smaller blood volumes present several challenges for clinical laboratories. Photo source: Khushbu Patel, PhD
The CDC has released new guidelines in response to the dramatic rise in prescription opioids overdoses in the last few years. Urine drug testing is recommended to help determine whether patients are taking opioids as prescribed or taking other drugs that might increase their risk of an overdose.
The American College of Cardiology and American Heart Association recommend that adults taking statins have regular cholesterol checks. For those whose blood cholesterol level is not adequately lowered, non-statin drugs may be considered.
In recognition of Medical Laboratory Professionals Week (April 24-30, 2016),we asked several lab professionals to list key facts that they think are important for patients and their healthcare practitioners to know about laboratory tests. See the top 10 list.
A new test developed by the CDC that distinguishes between Zika, dengue and chikungunya viral infections is now available through certain public health laboratories.
Photo source: CDC, Cynthia Goldsmith
Could a blood test for multiple biomarkers improve diagnosis for depression and provide a breakthrough for certain patient populations?
When it comes to evaluating a woman's risk for hereditary breast and ovarian cancer, her father's family history of cancer is just as important to take into consideration as her mother's and is necessary to be able to determine whether testing for BRCA mutations should be considered. Photo source: CDC, Dawn Arlotta
Scientists have recently reported finding in the upper Midwest a new species of tick-borne bacteria that can cause Lyme disease. The new species has been given the name Borrelia mayonii after the Mayo Clinic where it was discovered. Photo source: CDC / James Gathany; William L. Nicholson, Ph.D.
Environmental lead testing and elevated blood lead levels in children living in Flint, MI revealed the extent of the city's water contamination problem.
Photo source: CDC, Richard Duncan
Recent technological advances are enabling the development of new tests that make medical screening, diagnosis, and monitoring less invasive, more affordable, and more patient-focused. Photo courtesy of Dong Jin Shin, Johns Hopkins University
The CDC has issued a travel alert for more than 20 countries, primarily in South and Central America and the Caribbean, because of an outbreak of Zika virus, an infection spread by mosquitos. Pregnant women are advised to postpone travel to these areas following reports of microcephaly in babies born to mothers who were infected with the Zika virus while pregnant. Photo source: CDC, James Gathany